Adult respiratory distress syndrome following cardiopulmonary bypass: Incidence, prophylaxis and management

Journal of Cardiovascular Surgery

Volumn 39, Issue 6, 1998, Pages 777-781

  Kaul, T K ^a   Fields, B L ^a   Riggins, L S ^a   Wyatt, D A ^a   Jones, Ch R ^a   Nagle, D ^a  

^a Baptist Medical Center   (United States)

Author keywords

Cardiopulmonary bypass; Coronary artey bypass; Respiratory distress syndrome, adult

Indexed keywords

COMPLEMENT INHIBITOR; DIURETIC AGENT; NITROUS OXIDE PLUS OXYGEN; SURFACTANT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COLLOID; CORONARY ARTERY BYPASS SURGERY; EMERGENCY SURGERY; FOLLOW UP; HUMAN; LUNG FUNCTION; LUNG VENTILATION; MAJOR CLINICAL STUDY; MORTALITY; PATIENT CARE; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; RETROSPECTIVE STUDY; SMOKING CESSATION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; ULTRAFILTRATION;

AGED; ANTIOXIDANTS; CARDIOPULMONARY BYPASS; COMPLEMENT INACTIVATOR PROTEINS; CORONARY ARTERY BYPASS; DIURETICS; DRUG THERAPY, COMBINATION; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; ULTRAFILTRATION;

EID: 0032449354     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ausbaugh DG. Acute respiratory distress in adults. Lancet 1967;2:319-23.
2. Bernard GR, Wie JM, Sprung CL. High dose corticosteroid in patients with ARDS. N Engl J Med 1987;317:1565-70.
3. Treasure T. A surgeons view of ARDS. Br J Hosp Med 1994; 52:108-14.
4. Llamas R, Forthman HJ. Respiratory distress syndrome in the adults after cardiopulmonary bypass. JAMA 1973;225:1183-6.
5. Gleb A, Kllein E. Hemodynamic and alveolar protein studies in non cardiogenic pulmonary oedema. Am Rev Respir Dis 1976;114: 831-5.
6. Tolley E, Meduri GU, Stenz F, Headley J, Tolley E, Leeper KV et al. Inflammatory cytokines in the BAL of ARDS. Chest 1993;104:151S.
7. do Canipo JL, Bertranou EG, Bigalli D, Areta M, Bottellini R, Becerra R. Exogenous pulmonary surfactant nebulization (EPSN) after cardiac surgery (CS) with cardiopulmonary bypass (CPBP). Chest 1993;103:189S.
8. Lewandowski K, Slama K, Rossaint R, Streich R, Keitel M, Gerlach H et al. Algorithm for treatment of ARDS. Chest 1992;102:174S.
9. Keogh B, Hunter AN, Morgan CJ, Evans TW. Causes of mortality in patients with ARDS. Br J Hosp Med 1990;43:26-35.
10. Montgomery AB, Stager MA, Carrico CJ, Hudson LD. Causes of mortality in patients with ARDS. Am Rev Respir Dis 1985;132:485-9.
11. Nieffman GF, Clark WR, Wax SD, Webb WR. Effects of smoke inhalation on pulmonary surfactant. Ann Surg 1981;119:171-81.
12. Elliot MJ. Ultrafiltration and modified ultrafiltration in pedriatric open heart operations. Ann Thorac Surg 1993;56:1518-22.
13. Rinaldo JE, Chirstman JW. Mechanism and mediators of ARDS. Clin Chest Med 1990;11:621-32.
14. Rinaldo JE. Mediation of ARDS by leucocytes. Chest 1986;89:590-3.
15. Hind CRK, Griffin JF, Pack S, Latchman YE, Drake HF, Jones HM et al. Effect of cardiopulmonary bypass on circulating concentration of leucocyte elastase and free radical activity. Cardiovasc Res 1988;22:37-41.
16. Hallman N. Evidence of surfactant abnormality in respiratory failure. J Clin Invest 1982;70:673.
17. Finn A, Paul Morgan B, Rebuck N, Klein N, Rogers CA, Hibbs M et al. Effect of inhibition of complement activation using recombinant soluble complement receptor 1 on neutrophil CD11b/CD18 and L selectin expression and release of IL-8 and elastase in simulate cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996; 111:45-54.
18. Johnson P, Thomson P, Hurst T, Prasad K, Wilson T, Murphy F et al. Neutrophil mediated acute lung injury after extracorporeal perfusion. J Thorac Cardiovasc Surg 1994;107:1193-202.
19. Friedman M, Wang SY, Sellke FW, Cohn WE, Weintraub RM, Johnson RG. Neutrophil adhesion blockade with NPC 15669 decreases pulmonary injury after total cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996;111:460-8.
20. Morioka K, Muraoka R, Chiba Y, Ihaja A, Kimura T, Noguti H et al. Leucocyte and platelet depletion with a blood cell separator. Effects on lung injury after cardiac surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996;111:451-9.
21. Meduri GU, Leeper KV, Tolley E, Stenz F. Inflammatory cytokine response to high dose corticosteroids in ARDS. Chest 1993;104:1.
22. Anderson HL III, Delius RE, Sinard JM, Mc Curry KR, Stanley CJ, Chapman RA et al. Early experience with ECMO in the modern era. Ann Thorac Surg 1992;53:553-63.
23. Iapol WM, Snider MT, Hill JD. ECMO in severe acute respiratory failure; a randomised prospective study. JAMA 1979;242:2193-6.
24. Kallis P, Al Saady NM, Bennett ED, Treasure T. Intra-arterial oxygenation in ARDS. Br J Hosp Med 1992;47:824-8.
25. Richman PS, Spragg RG, Merritt TA, Robortson B, Curstedt T. Administration of porcine lung surfactant to humans with ARDS initial experience. Am Rev Respir Dis 1987;135:A5.